Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: The Thrifty Investor who wrote (961)	8/3/1998 5:23:00 PM
From: Harvey Barish	Read Replies (1) \| Respond to of 1605

I believe that there are quite a few new commercial sites in the sales pipeline. Check the web site periodically. I spoke to the company this morning and the person who answered the phone said that they update the list on the 15th of the month. Also, the new clinical trials for CHF could be an even bigger market for EECP if the clinicals show that heart failure could be treated with counter pulsation. I think this would put EECP in the category of emergency treatment as opposed to only being used for chronic ailment therapy. If I am right, every hospital would be a sales target.